429 related articles for article (PubMed ID: 19062400)
1. Severe pruritus after completing pegylated interferon for hepatitis C.
Hoffman CJ; Ray SC
AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400
[TBL] [Abstract][Full Text] [Related]
2. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection: a possible promoting agent in porphyria cutanea tarda.
Antonov K; Krastev Z; Teoharov P; Zaharieva E; Alexiev A; Ivanova A; Adjarov D
Ital J Gastroenterol; 1996 Dec; 28(9):482-6. PubMed ID: 9131391
[TBL] [Abstract][Full Text] [Related]
5. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Cacoub P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B210-9. PubMed ID: 12180291
[No Abstract] [Full Text] [Related]
7. [Cutaneous pigmentation, only manifestation of porphyria cutanea tarda in a HIV-1 positive patient].
Pascual C; García-Patos V; Bartralot R; Pedragosa R; Capdevila M; Barberá J; Castells A
Ann Dermatol Venereol; 1996; 123(4):262-4. PubMed ID: 8763751
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
Linde Y; Harper P; Floderus Y; Ros AM
Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
[TBL] [Abstract][Full Text] [Related]
9. [Porphyria cutanea tarda accompanying hepatitis C].
Yamazaki Y; Kiyosawa K
Nihon Rinsho; 1995 Jun; 53(6):1468-73. PubMed ID: 7542354
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
[TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.
O'Connor WJ; Badley AD; Dicken CH; Murphy GM
Mayo Clin Proc; 1998 Sep; 73(9):895-7. PubMed ID: 9737229
[TBL] [Abstract][Full Text] [Related]
12. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
[No Abstract] [Full Text] [Related]
13. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
[TBL] [Abstract][Full Text] [Related]
14. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
Okano J; Horie Y; Kawasaki H; Kondo M
Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
[TBL] [Abstract][Full Text] [Related]
15. Porphyria cutanea tarda associated with human immunodeficiency virus infection.
Drobacheff C; Derancourt C; Van Landuyt H; Devred D; de Wazieres B; Cribier B; Rey D; Lang JM; Grosieux C; Kalis B; Laurent R
Eur J Dermatol; 1998; 8(7):492-6. PubMed ID: 9854161
[TBL] [Abstract][Full Text] [Related]
16. [Porphyria cutanea tarda and hepatitis C virus infection].
Held E; Petersen CS
Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
[TBL] [Abstract][Full Text] [Related]
17. [Selection for treatment of hepatitis C co-infected patients for ].
Findor J; Bessone F; Corti M
Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
[No Abstract] [Full Text] [Related]
18. [Porphyria cutanea tarda--new views on its pathogenesis and therapy].
Falkiewicz B; Dabrowska E; Jabłońska-Kaszewska I
Wiad Lek; 1997; 50(4-6):106-11. PubMed ID: 9381711
[TBL] [Abstract][Full Text] [Related]
19. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
McGovern B; Bica I
Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
[No Abstract] [Full Text] [Related]
20. [Treatment of hepatitis C virus associated extrahepatic manifestations].
Duclos-Vallée JC
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
